78 related articles for article (PubMed ID: 34516351)
1. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
Wang C; Yang M; Gu X; Gu Y
Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
[TBL] [Abstract][Full Text] [Related]
2. Morphine promotes tumorigenesis and cetuximab resistance via EGFR signaling activation in human colorectal cancer.
Lu H; Zhang H; Weng ML; Zhang J; Jiang N; Cata JP; Ma D; Chen WK; Miao CH
J Cell Physiol; 2021 Jun; 236(6):4445-4454. PubMed ID: 33184860
[TBL] [Abstract][Full Text] [Related]
3. Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9.
Hu TT; Yang JW; Yan Y; Chen YY; Xue HB; Xiang YQ; Ye LC
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33048115
[TBL] [Abstract][Full Text] [Related]
4. LMTK3 confers chemo-resistance in breast cancer.
Stebbing J; Shah K; Lit LC; Gagliano T; Ditsiou A; Wang T; Wendler F; Simon T; Szabó KS; O'Hanlon T; Dean M; Roslani AC; Cheah SH; Lee SC; Giamas G
Oncogene; 2018 Jun; 37(23):3113-3130. PubMed ID: 29540829
[TBL] [Abstract][Full Text] [Related]
5. LMTK3 is implicated in endocrine resistance via multiple signaling pathways.
Stebbing J; Filipovic A; Lit LC; Blighe K; Grothey A; Xu Y; Miki Y; Chow LW; Coombes RC; Sasano H; Shaw JA; Giamas G
Oncogene; 2013 Jul; 32(28):3371-80. PubMed ID: 22869149
[TBL] [Abstract][Full Text] [Related]
6. α-Hederin induces paraptosis by targeting GPCRs to activate Ca
Rao X; Li Z; Zhang Q; Lai Y; Liu J; Li L; Cheng H; Shen W; Sun D
Cancer Med; 2024 Apr; 13(8):e7202. PubMed ID: 38659391
[TBL] [Abstract][Full Text] [Related]
7. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.
Xu Y; Zhang H; Lit LC; Grothey A; Athanasiadou M; Kiritsi M; Lombardo Y; Frampton AE; Green AR; Ellis IO; Ali S; Lenz HJ; Thanou M; Stebbing J; Giamas G
Sci Signal; 2014 Jun; 7(330):ra58. PubMed ID: 24939894
[TBL] [Abstract][Full Text] [Related]
8. LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer.
Xu Y; Zhang H; Nguyen VT; Angelopoulos N; Nunes J; Reid A; Buluwela L; Magnani L; Stebbing J; Giamas G
Cell Rep; 2015 Aug; 12(5):837-49. PubMed ID: 26212333
[TBL] [Abstract][Full Text] [Related]
9. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.
Han Y; Peng Y; Fu Y; Cai C; Guo C; Liu S; Li Y; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
Adv Sci (Weinh); 2020 Jul; 7(13):2000112. PubMed ID: 32670759
[TBL] [Abstract][Full Text] [Related]
10. Intestinal metabolite xylulose inhibits colorectal cancer by inducing apoptosis through the MAPK signalling pathway.
Hu Q; Zheng Q; Du X; Yang Z; Tian Q; Liang L; Zhao X; Bai H; Liu Y; Zhao M; Fu X
Toxicol Appl Pharmacol; 2024 Jun; 487():116960. PubMed ID: 38735592
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Effect of Cinnamon Polyphenolic Components in Colorectal Cancer Cell Lines.
Palmioli A; Forcella M; Oldani M; Angotti I; Sacco G; Fusi P; Airoldi C
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003308
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer.
Dong W; Li N; Pei X; Wu X
Oncol Lett; 2018 Apr; 15(4):4207-4214. PubMed ID: 29541187
[TBL] [Abstract][Full Text] [Related]
13. Chemoinformatics and machine learning techniques to identify novel inhibitors of the lemur tyrosine kinase-3 receptor involved in breast cancer.
Alrumaihi F
Front Mol Biosci; 2024; 11():1366763. PubMed ID: 38638686
[TBL] [Abstract][Full Text] [Related]
14. Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics.
Cutshaw G; Hassan N; Uthaman S; Wen X; Singh B; Sarkar A; Bardhan R
Anal Chem; 2023 Sep; 95(35):13172-13184. PubMed ID: 37605298
[TBL] [Abstract][Full Text] [Related]
15. A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy.
Gelfo V; Mazzeschi M; Grilli G; Lindzen M; Santi S; D'Uva G; Győrffy B; Ardizzoni A; Yarden Y; Lauriola M
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261609
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted role of lemur tyrosine kinase 3 in health and disease.
Ditsiou A; Gagliano T; Samuels M; Vella V; Tolias C; Giamas G
Open Biol; 2021 Sep; 11(9):210218. PubMed ID: 34582708
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer.
Li G; Liu J
Evid Based Complement Alternat Med; 2021; 2021():2280440. PubMed ID: 34557254
[TBL] [Abstract][Full Text] [Related]
18. The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab
Baysal H; De Pauw I; Zaryouh H; Peeters M; Vermorken JB; Lardon F; De Waele J; Wouters A
Front Immunol; 2021; 12():737311. PubMed ID: 34557197
[TBL] [Abstract][Full Text] [Related]
19. Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways.
Kamashev D; Shaban N; Lebedev T; Prassolov V; Suntsova M; Raevskiy M; Gaifullin N; Sekacheva M; Garazha A; Poddubskaya E; Sorokin M; Buzdin A
Cells; 2023 Aug; 12(16):. PubMed ID: 37626832
[TBL] [Abstract][Full Text] [Related]
20. The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.
Agnarelli A; Lauer Betrán A; Papakyriakou A; Vella V; Samuels M; Papanastasopoulos P; Giamas C; Mancini EJ; Stebbing J; Spencer J; Cilibrasi C; Ditsiou A; Giamas G
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
